We are live on ! Find out more
AA

AlphaCentric Advisors Portfolio holdings

AUM $118M
This Fund
S&P 500
This Quarter Est. Return
+6.03%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$240M
AUM Growth
+$33.2M
Cap. Flow
+$24.9M
Cap. Flow %
10.4%
Top 10 Hldgs %
83.63%
Holding
243
New
78
Increased
59
Reduced
41
Closed
38

Sector Composition

Rank Sector Weight
1 Real Estate 16.47%
2 Healthcare 9.94%
3 Technology 2.63%
4 Industrials 1.15%
5 Materials 0.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ROL icon
176
Rollins
ROL
$18.6B
$54K 0.02%
+1,391
New +$53.9K
TMO icon
177
Thermo Fisher Scientific
TMO
$211B
$54K 0.02%
+116
New +$54.4K
AERI
178
DELISTED
Aerie Pharmaceuticals
AERI
$54K 0.02%
4,000
+3,900
+3,900% +$47.1K
VIE
179
DELISTED
Viela Bio, Inc. Common Stock
VIE
$54K 0.02%
1,500
DG icon
180
Dollar General
DG
$25.9B
$53K 0.02%
252
-22
-8% -$4.7K
DHR icon
181
Danaher
DHR
$135B
$53K 0.02%
+268
New +$53.7K
WMT icon
182
Walmart Inc
WMT
$871B
$50K 0.02%
1,038
-90
-8% -$4.37K
LLY icon
183
Eli Lilly
LLY
$1.07T
$49K 0.02%
292
-24
-8% -$3.58K
CLX icon
184
Clorox
CLX
$11.6B
$48K 0.02%
237
-20
-8% -$4.14K
ABBV icon
185
AbbVie
ABBV
$458B
$46K 0.02%
425
AKAM icon
186
Akamai
AKAM
$16.8B
$45K 0.02%
432
-38
-8% -$3.98K
BMY icon
187
Bristol-Myers Squibb
BMY
$127B
$44K 0.02%
710
CPB icon
188
Campbell Soup
CPB
$6.51B
$44K 0.02%
900
-72
-7% -$3.48K
RCKT icon
189
Rocket Pharmaceuticals
RCKT
$348M
$44K 0.02%
800
+350
+78% +$12.8K
TAK icon
190
Takeda Pharmaceutical
TAK
$55.1B
$40K 0.02%
2,200
KDNY
191
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$40K 0.02%
+2,500
New +$37.7K
CTXS
192
DELISTED
Citrix Systems Inc
CTXS
$39K 0.02%
299
-25
-8% -$3.18K
ALBO
193
DELISTED
Albireo Pharma Inc
ALBO
$38K 0.02%
+1,000
New +$36.4K
INSM icon
194
Insmed
INSM
$23.2B
$37K 0.02%
1,100
+447
+68% +$16.3K
SYRE icon
195
Spyre Therapeutics
SYRE
$8.87B
$31K 0.01%
160
+40
+33% +$8.29K
BFK
196
DELISTED
BlackRock Municipal Income Trust
BFK
$29K 0.01%
1,900
CHRS icon
197
Coherus Oncology
CHRS
$217M
$28K 0.01%
1,600
MYJ
198
DELISTED
Blackrock Muni Yield New Jersey Fund, Inc.
MYJ
$27K 0.01%
1,900
MUS
199
DELISTED
BLACKROCK MUNIHOLDINGS QUALITY FUND, INC.
MUS
$27K 0.01%
2,050
BFY
200
DELISTED
BlackRock New York Municipal Income Trust II
BFY
$25K 0.01%
+1,720
New +$24.2K

Similar funds

AlphaCentric Advisors's Q4 2020 Portfolio in Review

As of Q4 2020, AlphaCentric Advisors held 243 positions worth $240M, up 16% from $207M the previous quarter. Its ten largest holdings account for 84% of the portfolio.

AlphaCentric Advisors deployed $24.9M of net new capital in Q4 2020, opening 78 new positions and adding to 59 existing holdings. Its largest new stake was Nano Dimension: 125,000 shares worth $1.14M.

By sector, the portfolio is most concentrated in Real Estate at 16% of assets, down from 17% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was iShares 1-3 Year Treasury Bond ETF, an estimated $3.98M trimmed.

  • AlphaCentric Advisors's largest Q4 2020 buy was Nano Dimension: 125,000 shares worth $1.14M.
  • AlphaCentric Advisors added most to Vanguard Mortgage-Backed Securities ETF in Q4 2020, an estimated $14.9M increase.
  • AlphaCentric Advisors's biggest Q4 2020 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $3.98M.
  • AlphaCentric Advisors fully exited FLIR Systems, Inc. (DE) Common Stock in Q4 2020, selling an estimated $896K.
  • AlphaCentric Advisors's ten largest holdings make up 84% of its $240M portfolio in Q4 2020.
  • AlphaCentric Advisors opened 78 new positions and closed 38 in Q4 2020.
  • AlphaCentric Advisors's portfolio value rose 16% quarter-over-quarter to $240M.

Based on AlphaCentric Advisors's 13F filing for Q4 2020, filed 11 Mar 2022.